SKU: D | Last Updated On: Sep 16 2019 | No. of Pages: 222 | Available Formats
The global Collagen & Gelatin Market for Regenerative Medicine is expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.
Gelatin and collagen are proteins that are mainly found in the skin and bones but are present throughout the human body.
After a specific age, the natural generation of collagen in the body diminishes. The absence of collagen aggravates and promotes chronic ailments such as osteoporosis, chronic wounds, cardiovascular diseases, bone and joint discomfort, and neurodegenerative disorders.
Chronic diseases can result in the organ and tissue loss which drives the development of the use of collagen and gelatin-based biomaterials for regenerative medicine.
The purpose of it in the field of regenerative medicine has been growing substantially over the past few decades owing to the significant advantage of being biodegradable, biocompatible, low immunogenicity, readily available, and highly versatile, boosting the growth of collagen and gelatin market for regenerative medicine.
The global market for the global Collagen & Gelatin Market for Regenerative Medicine is primarily driven by the rising prevalence of chronic diseases, diabetes and the rapid growth in the geriatric population.
According to the U.S. National Institutes of Health, 2017, chronic wounds affect 6.5 million people in the U.S., and the numbers will likely increase. Other factors are the increase in global healthcare expenditure and the availability of government & private funding for R&D support the development of the collagen & gelatin market.
Furthermore, increasing research on collagen and gelatin-based products and technological advances in regenerative medicine propel the market.
However, the availability of alternative biomaterials in the market may hinder the collagen & gelatin market growth.
By type, the global collagen and gelatin market for regenerative medicine is mainly segmented into collagen and gelatin.
By source, the global collagen and gelatin market for regenerative medicine is segmented into porcine, bovine, marine, and others.
The bovine collagen and gelatin segment holds the largest market share is owing to its abundant availability, the lower cost and extensive range of applications in the tendon reinforcement, skin & wound healing, hernia repair, and plastic & reconstructive surgery.
By application, the global collagen and gelatin market for regenerative medicine includes orthopedics, cardiovascular, wound care, and others. The orthopedics sector accounts for the significant share of the worldwide collagen and gelatin market for regenerative medicines, owing to the high prevalence of osteoporosis across the globe due to the aging population and growing obesity.
According to the International Osteoporosis Foundation (IOF), osteoporosis affects almost 70 million Chinese over the age of 50.
The wound care segment is expected to be the fastest growing share, particularly in the gelatin market. It can be attributed to the rise in chronic wounds and diabetes. Gelatin hydrogels are favored as they help in healing while protecting the injury.
North America dominates the global collagen & gelatin market for regenerative medicine, and it is primarily attributed to the chronic wounds, high incidence of osteoporosis, increasing the prevalence of heart diseases and diabetes in the region. For instance, according to International Osteoporosis Foundation (IOF), osteoporosis affects approximately 1.4 million Canadians, mainly postmenopausal women and the elderly, affecting 1 in 4 women and more than 1 in 8 men over the age of 50 years
. In the United States, an estimated 44 million people have osteoporosis, or low bone mass, which represents 55% of the people aged 50 plus.
The region’s broad base of the patient population and the extensive research activities undertaken by a majority of prominent local players contribute to the growth of North America’s share in the collagen & gelatin market. Other factors that propel this market are the availability of high investment and funding.
Asia-Pacific region is expected to witness significant growth during the forecast period, owing to its extensive patient population.
The rise in cardiovascular disease and diabetics in the region is expected to propel the market. Moreover, the increasing number of research studies and growth opportunities for market players in developing economies of the area help the market growth.
Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches along with increased focus on R&D are other ways the leading players improve their market presence.
In January 2019, Generex Biotechnology Corporation completed the acquisition Olaregen Therapeutix Inc. Olaregen Therapeutics is preparing to launch its proprietary, patented, collagen wound healing matrix, Excellagen, which is FDA 510K-Cleared.
Collagen Solutions, the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, entered into a new agreement with Olaregen Therapeutics to manufacture and produce Excellagen.
January 2019, Nitta Gelatin, in collaboration with Ehime University Graduate School of Medicine, published findings from a recent double-blind, placebo-controlled human clinical study investigating the effect of porcine collagen peptide supplementation on cardiovascular health in older individuals.
October 2018, GELITA is focusing on sports nutrition with TENDOFORTE. The company has added specific collagen peptides to its portfolio to keep tendons and ligaments strong and flexible.
They minimize the risk of damage and enable faster regeneration after an injury. TENDOFORTE enables the development of tailor-made sports products with a focus on muscle growth, strong bones, and joint health.
March 2018, Nitta Gelatin launched of new pharmaceutical gelatin, DRG Gelatin, explicitly designed to inhibit cross-linkage reactions, and improve dissolution in soft capsule applications.
This clean label product is created without additives or chemical modification, and delivers the same gel strength as traditional gelatin while offering improved soft capsule quality over shelf-life.
February 2018, Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral-based medical devices announced its first entrance into the India market with two product lines, OssiMend bone graft matrices from its Spine Business Unit and DuraMatrix membranes from its Dural Repair Business Unit.
The major players operating in the global gelatin market for regenerative medicine include GELITA AG, Nitta Gelatin, and PB Gelatin (now PB Leiner).
Why Purchase the Report?
• Visualize the composition of the global Collagen & Gelatin Market for Regenerative Medicine across each indication, in terms of type and treatment options, highlighting the critical commercial assets and players.
• Identify business opportunities in global Collagen & Gelatin Market for Regenerative Medicine by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of the global Collagen & Gelatin for Regenerative Medicine Market – level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the principal products of all major market players
• Equipment Suppliers/ Buyers
• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
1.1. Research Methodology
1.2. Scope of the market
2.1. Key Trends and Developments
3.3. Supply Chain Analysis
3.5. Key Developments
4. Market Segmentation Analysis
4.1. By Type
4.2. By Source
4.3. By Application
4.3.2. Wound Care
5. Regional, Country-level Analysis
5.1. Geographic Overview
5.2. North America
5.3.4. Rest of Europe
5.4. South America
5.4.3. Rest of South America
5.5. Asia Pacific
5.5.5. Rest of Asia Pacific
6. Competitive Analysis
6.1. Competitive Scenario
6.2. Key Strategies adopted by Manufacturers
6.3. Product Benchmarking
7. Company Profiles
7.1. Nitta Gelatin, Inc.
7.2. Integra LifeSciences Holding Corporation
7.3. Collagen Solutions plc
7.4. GELITA AG
7.5. Collagen Matrix, Inc.
7.6. Royal DSM
7.7. Vornia Biomaterials
7.8. NuCollagen LLC
7.9. PB Gelatin (now PB Leiner)
7.10. XIAMEN HYFINE GELATIN CO., LTD
8.2. List of Tables
8.3. Expert Panel Validation
8.5. Contact Us